Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic reviewHAMERS, Raph L; SMIT, Pieter W; STEVENS, Wendy et al.Antiviral therapy (London). 2009, Vol 14, Num 5, pp 819-829, issn 1359-6535, 11 p.Article

Interaction between antiretroviral drugs and acenocoumarolVVELZEN, Marieke Eb; VAN DEN BERK, Guido El; HAMERS, Raph L et al.Antiviral therapy (London). 2011, Vol 16, Num 2, pp 249-252, issn 1359-6535, 4 p.Article

The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan AfricaHAMERS, Raph L; DERDELINCKX, Inge; VAN VUGT, Michèle et al.Antiviral therapy (London). 2008, Vol 13, Num 5, pp 625-639, issn 1359-6535, 15 p.Article

Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysisHAMERS, Raph L; SAWYER, A. W; TUOHY, Martin et al.AIDS (London). 2012, Vol 26, Num 13, pp 1663-1672, issn 0269-9370, 10 p.Article

Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapineHAMERS, Raph L; WENSING, Annemarie Mj; BACK, Nicole Kt et al.Antiviral therapy (London). 2011, Vol 16, Num 1, pp 115-118, issn 1359-6535, 4 p.Article

Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.The Journal of infectious diseases. 2012, Vol 205, Num 11, pp 1739-1744, issn 0022-1899, 6 p.Article

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance NetworkHAMERS, Raph L; STRAATSMA, Elske; WELLINGTON, Maureen et al.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S261-S265, SUP4Article

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out StavudineTANG, Michele W; RHEE, Soo-Yon; RUXRUNGTHAM, Kiat et al.The Journal of infectious diseases. 2013, Vol 207, issn 0022-1899, S70-S77, SUP2Article

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyHAMERS, Raph L; WALLIS, Carole L; NANKYA, Immaculate et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 750-759, issn 1473-3099, 10 p.Article

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of anti retrovi ral treatment i n resource-limited settings: a global collaborative study and meta-regression analysisGUPTA, Ravindra K; JORDAN, Michael R; BERTAGNOLIO, Silvia et al.Lancet (British edition). 2012, Vol 380, Num 9849, pp 1250-1258, issn 0140-6736, 9 p.Article

Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in KampalaNDEMBI, Nicaise; HAMERS, Raph L; SIGALOFF, Kim C. E et al.AIDS (London). 2011, Vol 25, Num 7, pp 905-910, issn 0269-9370, 6 p.Article

Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling studyNICHOLS, Brooke E; SIGALOFF, Kim C. E; KITYO, Cissy et al.AIDS (London). 2014, Vol 28, Num 1, pp 73-84, issn 0269-9370, 12 p.Article

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-PacificHAMERS, Raph L; OYOMOPITO, Rebecca; ABDALLAH, Saade et al.International journal of epidemiology. 2012, Vol 41, Num 1, pp 43-54, issn 0300-5771, 12 p.Article

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyHAMERS, Raph L; SCHUURMAN, Rob; OSIBOGUN, Akin et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 4, pp 307-317, issn 1473-3099, 11 p.Article

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesHAMERS, Raph L; SIGALOFF, Kim C. E; OSIBOGUN, Akin et al.Clinical infectious diseases. 2012, Vol 54, Num 11, pp 1660-1669, issn 1058-4838, 10 p.Article

Short Communication High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, KenyaSIGALOFF, Kim C. E; MANDALIYA, Kishor; HAMERS, Raph L et al.AIDS research and human retroviruses. 2012, Vol 28, Num 9, pp 833-837, issn 0889-2229, 5 p.Article

Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African CountriesSIGALOFF, Kim C. E; HAMERS, Raph L; OSIBOGUN, Akin et al.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S294-S299, SUP4Article

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 23-31, issn 1525-4135, 9 p.Article